TABLE 2.

Retention in HIV medical care among Hispanics/Latinos aged ≥13 years with HIV infection diagnosed by December 31, 2009,^* who were alive on December 31, 2010, by selected characteristics — National HIV Surveillance System, 19 jurisdictions,^† United States

Characteristic	No.	Retention in care in 2010§
		No.	(%)
Sex
Male	53,918	28,434	(52.7)
Female	16,295	9,735	(59.7)
Age group on December 31, 2009 (yrs)
13–24	2,880	1,592	(55.3)
25–34	10,447	5,449	(52.2)
35–44	21,778	11,823	(54.3)
45–54	23,277	12,955	(55.7)
≥55	11,831	6,350	(53.7)
Transmission category ¶
Male-to-male sexual contact	34,254	18,515	(54.1)
Injection drug use
Male	11,060	5,263	(47.6)
Female	4,980	2,952	(59.3)
Male-to-male sexual contact and injection drug use	3,669	2,043	(55.7)
Heterosexual contact**
Male	4,266	2,256	(52.9)
Female	10,670	6,378	(59.8)
Other††
Male	668	356	(53.3)
Female	645	404	(62.7)
Total	70,213	38,169	(54.4)

Abbreviation: HIV = human immunodeficiency virus.

^*Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. Hispanics/Latinos can be of any race.

^†The 19 jurisdictions were California (Los Angeles County and San Francisco only), Delaware, District of Columbia, Georgia, Hawaii, Illinois, Indiana, Iowa, Louisiana, Michigan, Minnesota, Missouri, Nebraska, New Hampshire, New York, North Dakota, South Carolina, West Virginia, and Wyoming.

^§Two or more CD4+ T-lymphocyte or viral load tests performed at least 3 months apart during 2010.

^¶Data statistically adjusted to account for missing transmission categories.

^**Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.

^††Includes persons with diagnosed infection attributed to hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.